-
A96192B
Dataset
EGAD00001006944
-
A95703B
Dataset
EGAD00001006942
-
ATAC data for Glioblastoma (EGAS00001003953, H016)
Dataset
EGAD00001006544
-
McGill EMC Release 4 for assay "smRNA-seq"
Dataset
EGAD00001001292
-
McGill EMC Release 4 for assay "Bisulfite-seq"
Dataset
EGAD00001001289
-
McGill EMC Release 4 for cell type "induced pluripotent stem cell"
Dataset
EGAD00001001276
-
SNP data for Ovarian cancer PRS (controls)
Dataset
EGAD00001008145
-
McGill EMC Release 4 for assay "RNA-seq"
Dataset
EGAD00001001290
-
McGill EMC Release 4 for assay "mRNA-seq"
Dataset
EGAD00001001291
-
A95728A
Dataset
EGAD00001006943
-
WXS files for Roussel-ATRT-TM
Dataset
EGAD00001009164
-
Additional WXS files for Roussel-ATRT-TM
Dataset
EGAD00001010265
-
Additional WGS files for Roussel-ATRT-TM
Dataset
EGAD00001010264
-
Genome-wide characterization of Kuwaiti Arab Population
Study
EGAS00001005034
-
WTCCC case-control study for Rheumatoid Arthritis - Combined Controls
Study
EGAS00000000012
-
WTCCC case-control study for Bipolar Disorder
Study
EGAS00000000001
-
RNA sequencing of baseline HCC PDX models
Dataset
EGAD50000000736
-
BLUEPRINT ATAC-seq data for cells in the haematopoietic lineages, from adult and cord blood samples
Study
EGAS00001001596
-
Reference single cell SNP array dataset from Coriell for training and validation of method for accurate single cell genotyping
Dataset
EGAD00001006376
-
ESGI - Molecular diagnosis for mitochondrial disorders (2017-08-29)
Dataset
EGAD00001003596
-
Paired-end Whole Exome-seq analysis of multi-centric lower grade glioma
Dataset
EGAD00001003795
-
RNA-Seq of novel miR (nmiR-1 and nmiR-2) overexpression and knockdown in BL
Dataset
EGAD00001001612
-
RNAseq of liver harvested from CDAHFD mice treated for 8 weeks with either the MGAT2 inhibitor compound BMS-963272 or vehicle
Study
EGAS00001006583
-
WES and WGS data for HGSC patient derived cell lines and fresh frozen tumor samples from same patients
Dataset
EGAD00001009330
-
Two lung cancer cell lines with EGFR mutations, PC-9 and KHM-3S, were either treated with Tarceva for 24 hours or left untreated. The gene expression profiles were examined by RNAseq, and the genome wide binding profiles of total STAT3 and pSTAT3 were characterized by ChIPseq.
Study
EGAS00001000793